Crossmark

Impact of T-cell chimerism on relapse after cord blood transplantation for hematological malignancies: Nagoya Blood and Marrow Transplantation Group study

Crossref DOI link: https://doi.org/10.1038/bmt.2016.323

Published Online: 2017-01-09

Published Print: 2017-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yokohata, E

Kuwatsuka, Y

Ohashi, H

Terakura, S

Kawashima, N

Seto, A

Kurahashi, S

Ozawa, Y

Goto, T

Imahashi, N

Nishida, T

Miyao, K

Sakemura, R

Kato, T

Sawa, M

Kohno, A

Sao, H

Iida, H

Kiyoi, H

Naoe, T

Miyamura, K

Murata, M

,
License Information

Text and Data Mining valid from 2017-01-09

Version of Record valid from 2017-01-09
More Information

Article History

First Online: 9 January 2017

Competing interests

: HK received research funding from Chugai Pharmaceutical Co. Ltd., Bristol-Myers Squibb, Kyowa Hakko Kirin Co. Ltd., Sumitomo Dainippon Pharma Co., Ltd., Zenyaku Kogyo Co. Ltd., FUJIFILM Corporation, Nippon Boehringer Ingelheim Co. Ltd. The remaining authors declare no conflict of interest.

Document is current

Any future updates will be listed below